These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29521246)

  • 41. Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.
    Kopciuch D; Kamal NN; Kamal NN; Hamdy NA; Paczkowska A; Zaprutko T; Ratajczak P; Fliciński J; Kus K; Nowakowska E
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
    Zondi S; Naidoo P
    BMC Health Serv Res; 2022 Aug; 22(1):1054. PubMed ID: 35982442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.
    Pellegrino P; Carnovale C; Cattaneo D; Perrone V; Antoniazzi S; Pozzi M; Napoleone E; Filograna MR; Clementi E; Radice S
    Health Policy; 2013 Nov; 113(1-2):216-20. PubMed ID: 24012386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.
    Alkayyal N; Cheema E; Hadi MA
    Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the knowledge of and attitudes towards pharmacovigilance among healthcare students in China: a cross-sectional study.
    Zhao Y; Yang L; Tan R; Yuan J
    BMC Med Educ; 2024 May; 24(1):570. PubMed ID: 38789989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education.
    Yu YM; Kim S; Choi KH; Jeong KH; Lee E
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):591-599. PubMed ID: 30417555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
    Sanghavi DR; Dhande PP; Pandit VA
    Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and Reporting of Adverse Drug Reactions Related to Antibiotics in Primary Healthcare in Greece.
    Geitona M; Toska A; Latsou D; Saridi M
    Curr Drug Saf; 2022; 17(3):217-224. PubMed ID: 34749626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physicians' knowledge and attitude towards adverse event reporting system and result to intervention--randomized nested trial among Bulgarian physicians.
    Stoynova V; Getov IN; Naseva EK; Lebanova HV; Grigorov EE
    Med Glas (Zenica); 2013 Aug; 10(2):365-72. PubMed ID: 23892860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacovigilance and radiologists: How well do they get along?
    Aydin OC; Aydin S; Guney HZ
    Br J Radiol; 2020 Nov; 93(1115):20200596. PubMed ID: 32903029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?
    Ibrahim DM; Shawki MA; Solayman MH; Sabri NA
    Int J Clin Pract; 2021 Nov; 75(11):e14731. PubMed ID: 34387008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
    Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
    Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowledge, Attitude, and Practice of Medical, Pharmacy, and Nursing Students Towards Pharmacovigilance and Adverse Drug Reaction Reporting at University of Gondar College of Medicine and Health Sciences, Northwest Ethiopia: A Cross-Sectional Study.
    Tekel MT; Bekalu AF; Sema FD
    Adv Med Educ Pract; 2021; 12():1129-1139. PubMed ID: 34629925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
    Zimmermann A; Gaworska-Krzeminska A; Flis A
    Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring pharmacovigilance knowledge and attitudes among healthcare sciences students: development and validation of a universal questionnaire.
    Živanović D; Mijatović Jovin V; Javorac J; Kvrgić S; Rašković A; Stojkov S; Kašiković Lečić S; Savić N; Kralj M; Milenković A
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1196-1214. PubMed ID: 35253176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
    Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
    Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.